Back
Greenwich LifeSciences 10K Form
Sell
42
GLSI
Greenwich LifeSciences
Last Price:
13.40
Seasonality Move:
-9.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GLSI News And Ratings
See the #1 stock for the next 7 days that we like better than GLSI
GLSI Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-2.58M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.38 |
| Price / Book: | 34.85 |
Profitability
| EPS (TTM): | -0.80000 |
|---|---|
| Net Income (TTM): | $-10.5M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Greenwich LifeSciences Earnings Forecast
Key Greenwich LifeSciences Financial Ratios
- Per Share Earnings over the last 6 years have been positive in 1 years.
Greenwich LifeSciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GLSI |
| Website: | greenwichlifesciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GLSI Technical Analysis vs Fundamental Analysis
Sell
42
Greenwich LifeSciences (GLSI)
is a Sell
Is Greenwich LifeSciences a Buy or a Sell?
-
Greenwich LifeSciences stock is rated a Sell
The current Greenwich LifeSciences [GLSI] share price is $13.51. The Score for GLSI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.